Borderlands 4 has had a rough go of things since launch, and so it's interesting to hear what the game's QA Lead has to say ...

Before a car rolls off the production line, manufacturers run virtual tests on it. Simulating tires is particularly ...

The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people ...

Rob Sullivan on what he did at Saint Joseph's, what his role will be at Rutgers, and how his experience prepared him for this ...

After a poor performance in defeat at West Ham over the weekend, we answer your pressing questions about Newcastle ...

An expert Q&A on new Rule 16.1 of the Federal Rules of Civil Procedure (FRCP), effective December 1, 2025, including how Rule 16.1 may impact multidistrict litigation (MDL) practice and case ...

An expert Q&A on the key considerations for companies in designing and implementing executive compensation clawbacks, ...

Can Caleb Williams turn things around with other second-year QBs flourishing? How to fix red-zone woes? Brad Biggs answers ...

To combine TruCytes Biomarker Controls with the Cell Q platform to enhance quality and automation.

Carbon Brief explores what the GGA is, why progress on adaptation has been challenging and what a successful outcome would look like in Belém.

Bernard Tourillon, president and CEO of HPQ Silicon Inc., holds cylindrical 18650 and 2170 cells in his office in Montreal.